Revenue increased 33.8% YoY to 1,016.352 million yen, operating loss of 381 million yen, ordinary loss of 413 million yen, and net loss attributable to owners of the parent of 530 million yen for the quarter. Secured funding by issuing new shares totaling 900 million yen and entering into a committed-term loan facility of 3,000 million yen. Change in consolidated scope, including ConvaNo becoming the new parent company, is also taking place.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"3624","jir_company_name":"Accel Mark Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-08-14","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/08\/3624-20260814-01.pdf","jir_short_summary":"Revenue increased 33.8% YoY to 1,016.352 million yen, operating loss of 381 million yen, ordinary loss of 413 million yen, and net loss attributable to owners of the parent of 530 million yen for the quarter. Secured funding by issuing new shares totaling 900 million yen and entering into a committed-term loan facility of 3,000 million yen. Change in consolidated scope, including ConvaNo becoming the new parent company, is also taking place.","jir_summary":"### Overview of Performance\nIn the third quarter cumulative, revenue rose sharply to 1,016.6 million yen year on year, while operating, ordinary, and net losses widened. Financial restructuring is underway to secure funds for investments in the healthcare domain. Funding framework was secured by issuing new shares totaling 900 million yen and by a committed facility loan of 3,000 million yen. This aims to improve the financial foundation, and organizational restructuring making ConvaNo the new parent is also progressing.\n\n### Outlook and Impact on Capital Policy\nNo full-year earnings forecast was incorporated in this results release, and there is potential for revisions considering fourth-quarter performance trends. While the funding base has significantly improved due to the third-party allotment and loan facility, continued business conditions such as exclusion of consolidated subsidiaries and becoming a listed group company require careful attention. Growth strategy including healthcare M&A and investments is pursued to stabilize earnings.","jir_financial_highlights":"Revenue: 1,016,352 (YoY +33.8%)\nOperating loss: \u25b3381,474 (YoY \u25b3334,541 deterioration)\nOrdinary loss: \u25b3413,220 (YoY \u25b3400,023 deterioration)\nNet income attributable to owners of the parent (quarter): \u25b3530,751 (YoY \u25b3498,789 deterioration)\nCash and deposits: Unknown (Unknown)","jir_category":"","jir_hashtags":"#AccelMark, #NewShareIssue, #HealthcareInvestment, #CapitalPolicy","jir_key_figures":"Revenue: 1,016,352 thousand yen (YoY +33.8%)\nOperating loss: \u25b3381,474 thousand yen\nOrdinary loss: \u25b3413,220 thousand yen\nNet income attributable to owners of the parent (quarter): \u25b3530,751 thousand yen\nNew share issue amount: 900,000,000 yen\nCredit facility limit: 30,000,000,000 yen\nIssued shares: 45,000,000 shares","jir_meta_title":"Accel Mark Announces Third-Party Allotment and 3.0 Billion Yen Loan Financing | Q3 FY2026 Results","jir_meta_description":"Accel Mark Q3 results overview. Revenue increases YoY, but operating, ordinary, and net losses widen. Explains 900 million yen funding via third-party allotment and 3.0 billion yen loan facility, with ConvaNo becoming new parent company. Outlines financial position and growth strategy.","jir_og_title":"Accel Mark Q3 Results \u2014 Strengthening Financing via New Share Issuance and 3.0 Billion Yen Loan","jir_og_description":"Accel Mark Q3 results overview. Revenue increases, but losses widen. Financing strengthened via new share issuance and loan, supporting healthcare growth strategy.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":61293,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-103993","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n